SEATTLE, June 28, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global thrombectomy devices market is estimated to be valued at US$ 1,371.6 Million in 2020 and is expected to exhibit a CAGR of 7.2% over the forecast period (2020-2027).
Key Trends and Analysis of the Global Thrombectomy Devices market:
The key players operating in the market are focusing on product development, launch, and approval of advanced thrombectomy devices with novel features, which are expected to drive the market growth over the forecast period.
For instance, in June 2018, MicroVention, Inc., a U.S.-based subsidiary of Terumo Corporation, announced the U.S. FDA (Food and Drug Administration) clearance for new indication of its device, SOFIA catheter (soft torque able catheter for intracranial access). This new approval will allow the product to be used in contact aspiration procedures for the treatment of acute ischemic stroke.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2254
Furthermore, key players operating in the global thrombectomy devices market are focusing on adoption of inorganic growth strategies such as collaboration and acquisition to increase their market presence in the global market.
For instance, in November 2018, Boston Scientific Corporation announced its plans to acquire BTG plc., a company headquartered in the U.K., which is a developer and marketer of products that are used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals.
Key Market Takeaways:
The global thrombectomy devices market is expected to exhibit a CAGR of 7.2% during the forecast period, owing to increasing incidence of stroke and thrombosis, and rising technological advancements in thrombectomy devices. For instance, in October 2020, CERENOVUS, a part of Johnson & Johnson medical devices companies, announced the European launch of CERENOVUS NIMBUS, which is developed to remove tough clots for successful revascularization in patients with acute ischemic stroke caused by a large vessel occlusion.
Among application, ischemic stroke segment is estimated to be valued at US$ 591.9 Million in 2020, and is expected to witness a CAGR of 7.7% and reach US$ 997.4 Million by 2027 owing to the increasing prevalence of ischemic stroke worldwide. For instance, according to the Centers for Disease Control and Prevention (CDC) 2017, each year, 795,000 people in the U.S. have a stroke and around 87% of all these cases are ischemic strokes, where thrombectomy devices can be used. Moreover, the American Heart Association estimates that stroke prevalence will increase by 3.4 million in the U.S. between 2012 and 2030.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2254
Competitive Landscape:
Key players operating in the global thrombectomy devices market include LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd.
Market Segmentation:
- Global Thrombectomy Devices Market, By Product Type:
- Mechanical Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Hydrodynamic Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- Global Thrombectomy Devices Market, By Application:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Superficial Vein Thrombosis
- Renal Vein Thrombosis (RVT)
- Arterial Thrombosis (Atherothrombosis)
- Ischemic Stroke
- Others
- Global Thrombectomy Devices Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Academic and Research Institutes
- Others
- Global Thrombectomy Devices Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- By Country
- North America
Related Market Intelligence Reports:
India Fertility Monitor Market, By Modality (Handheld and Tabletop), By Type (Ovulation Predictor Monitor and Urine & Saliva-based Monitor), By End User, (Hospitals, Fertility Clinics, and Homecare Settings), By Region (North India, South India, East India, West India, Central India, and North East India) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
Read more: https://www.coherentmarketinsights.com/market-insight/india-fertility-monitor-market-4480
Orthopedic Biomaterial Market, By Material Type (Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites), By Application (Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation), By End User (Hospitals, Orthopedic Clinics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Read more: https://www.coherentmarketinsights.com/market-insight/orthopedic-biomaterial-market-4474
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.